More forecasts: Atlanta 30 day forecast
FDA-Approved Gene Fix Lets Deaf Kids Hear For The First Time
May 31, 2026
Updated CHORD trial numbers presented in Seoul suggest most children with otoferlin‑related deafness gained meaningful hearing after Otarmeni treatment. The therapy was FDA‑cleared in April.
Cancer Shot Stuns Docs as Head and Neck Tumors Vanish in Trial
May 31, 2026
Early trial data show amivantamab shrank—and in some patients erased—tumors in treatment‑resistant head and neck cancer, with results set for ASCO on Sunday. Investigators call the responses striking but preliminary.












